Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from Amneal Pharmaceuticals ( (AMRX) ).
On January 15, 2025, Amneal Pharmaceuticals, Inc. announced a report filed under the Securities Exchange Act of 1934, signed by Anastasios Konidaris, the Executive Vice President and Chief Financial Officer. This release reflects the company’s adherence to regulatory requirements and maintains transparency with stakeholders.
More about Amneal Pharmaceuticals
YTD Price Performance: 1.16%
Average Trading Volume: 1,082,025
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.43B
Learn more about AMRX stock on TipRanks’ Stock Analysis page.
